Revision as of 11:53, 19 October 2020

Resources

Cases

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

This is a facutal case.

@@ Line 2: / Line 2: @@
 |Resource Type=Cases
 |Title=Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
-|Is About=The study by Drs X and Y and the accompanying Editorial by Drs Z and Q  regarding rofecoxib illustrate the recurring problem of discretionary or data-driven analysis<ref>FitzGerald, Garret A. "Guest authorship, mortality reporting, and integrity in rofecoxib studies." ''JAMA'' 300.8 (2008): 900-906.</ref> This is a facutal case.
+|Is About=This is a facutal case.
 <references />
-|Important Because=Given the possibility of selective analysis based on observed data and the risk of positive results due to chance alone, it is critical to know in detail which analyses were prespecified and when the prespecification occurred<ref>FitzGerald, Garret A. "Guest authorship, mortality reporting, and integrity in rofecoxib studies." ''JAMA'' 300.8 (2008): 900-906.</ref>.
+|Important Because=<br />
 <references />
 |Important For=Researchers
@@ Line 15: / Line 15: @@
 }}
 {{Tags
-|Involves=Drs Psaty; Kronmal
 |Has Location=USA; United States
 |Has Virtue And Value=Honesty; Reliability